VGI Health Technology (XNEC:VTL) Dividend Yield % : 0.00% (As of May. 29, 2024)

View and export this data going back to 2021. Start your Free Trial

What is VGI Health Technology Dividend Yield %?

As of today (2024-05-29), the Trailing Annual Dividend Yield of VGI Health Technology is 0.00%.

The historical rank and industry rank for VGI Health Technology's Dividend Yield % or its related term are showing as below:

XNEC:VTL's Dividend Yield % is not ranked ^*
in the Biotechnology industry.
Industry Median: 1.52
* Ranked among companies with meaningful Dividend Yield % only.

VGI Health Technology's Dividend Payout Ratio for the six months ended in . 20 was 0.00.

As of today (2024-05-29), the Forward Dividend Yield % of VGI Health Technology is 0.00%.

VGI Health Technology's Dividends per Share for the six months ended in . 20 was A$0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

VGI Health Technology Dividend Yield % Historical Data

The historical data trend for VGI Health Technology's Dividend Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

VGI Health Technology Dividend Yield % Chart

VGI Health Technology Annual Data

Trend

Dividend Yield %

VGI Health Technology Semi-Annual Data

Dividend Yield %

Competitive Comparison of VGI Health Technology's Dividend Yield %

For the Biotechnology subindustry, VGI Health Technology's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

VGI Health Technology's Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, VGI Health Technology's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where VGI Health Technology's Dividend Yield % falls into.

VGI Health Technology Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

VGI Health Technology (XNEC:VTL) Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.

VGI Health Technology Dividend Yield % Related Terms

Thank you for viewing the detailed overview of VGI Health Technology's Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

VGI Health Technology (XNEC:VTL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » VGI Health Technology Ltd (XNEC:VTL) » Definitions » Dividend Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

19 Martin Place, Level 45, Suite 03, Sydney, NSW, AUS, 2003

Website

https://www.vgiht.com

VGI Health Technology Ltd develops and commercializes evidence-based nutraceuticals and pharmaceuticals. It has two evidence-based nutraceutical products ready for commercial launch in the US as well as a therapeutic drug development program. The nE1-Heart targets maintenance of heart health - tocotrienols have a similar mode of action (inhibition of HMCG CoA biosynthesis) as statins, the Gold Standard for treatment of hyperlipidaemia; and nE1-Eliteth that reduces Delayed Onset Muscle Soreness, improves muscle recovery after exercise, exercise endurance and maintenance of peak muscle power.

VGI Health Technology (XNEC:VTL) Headlines

No Headlines